A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine-Reference-Cited by-同舟云学术

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

Published:2011-10 Issue:43 Volume:29 Page:7514-7522
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Porter David W.,Thompson Fiona M.,Berthoud Tamara K.,Hutchings Claire L.,Andrews Laura,Biswas Sumi,Poulton Ian,Prieur Eric,Correa Simon,Rowland Rosalind,Lang Trudie,Williams Jackie,Gilbert Sarah C.,Sinden Robert E.,Todryk Stephen,Hill Adrian V.S.

Funder

European Malaria Vaccine Initiative

European Vaccine Initiative

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. The global distribution of clinical episodes of Plasmodium falciparum malaria;Snow;Nature,2005

2. WHO. World Malaria Report; August 2008.

3. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites;Hoffman;J Infect Dis,2002

4. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses;Prieur;Proc Natl Acad Sci U S A,2004

5. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites;Kumar;Nature,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Feeding Systems for Vector-Borne Disease Studies;Biology;2024-03-15

2. Benefits of Combining Molecular Biology and Controlled Human Infection Model Methodologies in Advancing Vaccine Development;Journal of Molecular Biology;2023-12

3. Genetic-Based Vaccine Vectors;Plotkin's Vaccines;2023

4. The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design;Current Opinion in Immunology;2022-10

5. Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages;Communications Biology;2022-08-01